Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study.
González-Martín, A J
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 2005 - 749-55 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0923-7534
10.1093/annonc/mdi147 doi
Adult
Aged
Carboplatin--administration & dosage
Chemotherapy, Adjuvant
Confidence Intervals
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Ovarian Neoplasms--mortality
Ovariectomy--methods
Paclitaxel--administration & dosage
Palliative Care
Probability
Prognosis
Quality of Life
Risk Assessment
Spain
Survival Analysis
Treatment Outcome
Randomized phase II trial of carboplatin versus paclitaxel and carboplatin in platinum-sensitive recurrent advanced ovarian carcinoma: a GEICO (Grupo Espanol de Investigacion en Cancer de Ovario) study. [electronic resource] - Annals of oncology : official journal of the European Society for Medical Oncology May 2005 - 749-55 p. digital
Publication Type: Clinical Trial; Clinical Trial, Phase II; Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0923-7534
10.1093/annonc/mdi147 doi
Adult
Aged
Carboplatin--administration & dosage
Chemotherapy, Adjuvant
Confidence Intervals
Dose-Response Relationship, Drug
Drug Administration Schedule
Female
Humans
Middle Aged
Neoplasm Recurrence, Local--drug therapy
Neoplasm Staging
Ovarian Neoplasms--mortality
Ovariectomy--methods
Paclitaxel--administration & dosage
Palliative Care
Probability
Prognosis
Quality of Life
Risk Assessment
Spain
Survival Analysis
Treatment Outcome